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Abstract 
Background: Despite advancing therapies, heart failure remains a progressive disease with high 
symptom burden. Advance care planning and palliative care assist in maximizing the quality of 
life for affected individuals. These interventions are supported by current heart failure guidelines 
yet application into practice is poor. Objective/aim: The purpose of this literature review is to 
investigate the relationship between advance care planning and palliative care interventions on 
the quality of life of adults with heart failure. Methods: A search of the literature was completed 
between October 20th, 2020 to November 10th, 2020. Databases searched include Academic 
Search Premier, CINAHL Plus, Cochrane Database of Systematic Reviews, PubMed, and SAGE 
Journals. Results/findings: Available research demonstrates that advance care planning and 
palliative care interventions increase quality of life in heart failure patients, but the quality and 
level of evidence remains low. The interventions also caused significant improvement to heart 
failure symptoms, healthcare resource utilization, and quality of death. 
Keywords: advanced care planning, advanced directives, palliative care, heart failure, 
cardiac failure, primary care, quality of life, wellbeing 
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Impact of Advance Care Planning in Heart Failure: A Literature Review 
Advance care planning (ACP) involves a voluntary discussion between the healthcare 
provider, patient, family members and any surrogate decisionmakers regarding patient’s health 
care goals while considering personal values, beliefs, and wishes (Ranganathan, et. al., 2014). 
During this discussion, the healthcare provider offers education on expectations of the disease 
course and treatment options based on the patient’s chronic conditions (Ranganathan, et. al., 
2014). The conversation may also involve the identification of a health care proxy, resuscitation 
preferences and creation of advance directives documents. While ACP discussions may be 
complex and challenging for both the provider and patient, they seek to support the patient’s 
autonomy and values with guidance from the health care team. Several previous studies 
demonstrate that patients who have not had ACP discussions do not have a clear understanding 
of their prognosis and opt for more aggressive treatments (Ranganathan, et. al., 2014). Though 
receiving these aggressive treatments does not always correlate with a longer survival or 
improved quality of life, and often results in poorly controlled symptoms and patient support 
(Ranganathan et. al., 2014).  
ACP discussions may introduce palliative care services and interventions, which seek to 
improve the quality of life for those with chronic illness. In addition, ACP is sometimes 
completed during palliative care specialist referrals. Palliative care is defined as an 
“interdisciplinary approach aimed at improving the quality of life of patients and caregivers by 
providing physical, emotional, psychosocial, and spiritual interventions” (von Schwarz et al., 
2020, p. 1). Palliative care intends to relieve distressing symptoms of chronic disease without 
intending to accelerate or postpone death (Ranganathan et. al., 2014). It was initially integrated 
into the treatment of oncology patients. The majority of current research on palliative care 
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continues to evaluate the oncology population, and has only recently gained appreciation for its 
role in other chronic diseases, including heart failure. 
The American College of Cardiology (ACC) and American Heart Association (AHA) 
define heart failure as “a complex clinical syndrome that results from any structural or functional 
impairment of ventricular filling or ejection of blood” (Yancy et al., 2013, p. e153). Heart failure 
severity is universally classified the New York Heart Association (NYHA) functional 
classification (Yancy et al., 2013, p. e153). This system of classification emphasizes the 
individual’s tolerance for activities and symptom severity and is labeled progressively from class 
I to IV (Yancy et al., 2013, p. e153). Those in class I have cardiac disease but without limitation 
of or symptoms during physical activity (Yancy et al., 2013). Class II is described as a slight 
limitation to physical activity, no symptoms at rest, but some symptoms during physical activity 
(Yancy et al., 2013). Patients in class III have marked limitation on physical activity, are 
comfortable at rest, but are symptomatic with less than ordinary activity (Yancy et al., 2013, p. 
e156). Class IV refers to those unable to carry on any physical activity without symptoms of 
heart failure and symptoms present at rest (Yancy et al., 2013, p. e156). 
Despite advancements in therapies, heart failure remains a progressive and terminal 
disease with high morbidity and mortality. Romanó (2020) states that “over half of all [heart 
failure] patients complain of dyspnea, pain, asthenia, and thirst” (p. 1). In addition, patients with 
symptomatic heart failure also have a high prevalence of depression and frequent 
hospitalizations, which significantly impacts quality of life (Wiskar et al., 2017). Despite the 
high degree of symptom burden of those with heart failure, ACP and palliative care consultations 
often do not occur until late in the disease process, close to the end of life (Romanó, 2020). 
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Approximately 2-20% of those living with advanced heart failure receive palliative care 
consultations, compared to up to 50% of oncology patients (Luo et al., 2016, p. 3).   
Traditional barriers to widespread application of palliative care and ACP in heart failure 
include the uncertain disease progression and perceived patient aversion to end-of-life 
discussions (Luo et al., 2016). The ACC/AHA guidelines acknowledge the benefits of palliative 
care and ACP interventions, and recommend they be applied in all stages of heart failure (Yancy 
et al., 2013). This recommendation is supported by the interventions’ association with 
significantly lower Medicare spending, lower likelihood of in-hospital death, and higher hospice 
care use (Yancy et al., 2013). However, these guidelines neglect to cite research that directly 
involves heart failure patients and instead reference research conducted on oncology patients 
(Yancy et al., 2013). While the use of ACP and palliative care for heart failure patients is 
supported by these guidelines, there is a disparity in the disease-specific research on this subject 
which may discourage use in practice.   
This background data identifies a gap between the ACP and palliative recommendations 
supported by the heart failure guidelines and those observed in usual care. The purpose of this 
literature review is to explore the available research on ACP or palliative care interventions on 
adults with heart failure and their impact on quality of life. It is notable to analyze the available 
disease-specific research on this topic and determine if there is evidence for this change to the 
usual heart failure care.  
Method 
 A search of the literature was completed between October 20th, 2020 to November 10th, 
2020. Databases searched include Academic Search Premier, CINAHL Plus, Cochrane Database 
of Systematic Reviews, PubMed, and SAGE Journals. The general subjects covered by each 
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database is covered in Table 1 in the attached Appendix. The databases were chosen based on 
their accessibility and inclusion of evidence-based articles in nursing and medical domains. The 
article search was limited to those published from January 2015 to November 2020. Restrictions 
added to the search were based on the capability of the database search engine, including full text 
availability, written in the English language, peer reviewed, and human species.   
The database search was guided by the research question, in adults with heart failure, 
how does advance care planning or palliative care interventions impact quality of life? A detailed 
data abstraction process and dates searched are outlined in Table 2 of the attached appendix. 
Search terms used included advance care planning, heart failure, cardiac failure, palliative care, 
and primary care. With search results of fifty articles or less, the titles were scanned to review 
their applicability to the research question.   
Titles were eliminated if their subjects pertained to a pediatric heart failure population, 
hospice care, or end-of-life transitions. Studies were also excluded if they only evaluated code 
status and cardio-pulmonary resuscitation decisions, as these decisions do not alone sufficiently 
represent the complexity of advance care planning. Greater preference was given to articles with 
a higher level of evidence. A total of sixteen articles were selected for abstract review and to 
determine their relevance to the research question. A review of references in these sixteen 
articles yielded three additional studies, which increased the total to nineteen articles.   
Studies included involve participants with a primary diagnosis of heart failure who 
underwent an ACP or palliative care intervention, with study outcomes related to quality of life. 
Participants must also be adults over the age of eighteen years. Specific inclusion and exclusion 
rationales for each of the nineteen articles are detailed in Table 3 of the appendix. Articles were 
excluded if their observed outcome focused on the number of advanced directives completed by 
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participants or participant perception of a palliative care intervention rather than changes to 
quality of life.   
After excluding inappropriate articles, a total of twelve studies remained for evaluation 
and literature review. Table 4 in the appendix offers an appraisal of these studies. Data extraction 
included the study purpose, population, sample size, level of evidence, variables and instruments 
utilized, intervention, findings and implications.     
Results 
Study Characteristics 
Eleven out of the twelve articles have quantitative research methods, and one involves 
qualitative methods. Of the quantitative studies, there are five systematic reviews, three 
randomized controlled trials, and three quasi-experimental studies. The one qualitative review 
involves an expert opinion of the benefits, barriers and applications of palliative care in patients 
with heart failure (Luo et al., 2016).   
Of the quantitative studies, sample size varied from 72 to 102,746 participants. Only five 
articles published an evaluation of demographic data, from which the mean age ranged from 63.5 
to 81.9 years (Bakitas et al., 2020; Kernick et al., 2018). The proportion of men in the studies 
ranged from 48.8% to 53.2% (Johnson et al., 2018; Wong et al., 2016). In all studies the 
participants heart failure was classified according to NYHA functional status, rather than 
ACC/AHA stages. None of the studies included participants of NYHA Class I. Only 2 included 
studies had participants with NYHA Class II status (Johnson et al., 2018; Wong et al., 2016). 
Wong et al. (2016) had nine participants from a total of eighty-four participants with class II 
status and Johnson et al. (2018) included six of their seventy-seven participants in this class. 
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Other studies either limited participants to NYHA Class III to IV status or did not 
demographically classify the participant’s heart failure class. 
All studies applied interventions in addition to usual care for heart failure.  Participants 
under both intervention and control arms of studies received usual care. Bakitas et al. (2020) 
describes usual care as consistent with current national heart failure guidelines, including heart 
failure education and receiving specialist cardiology care. However, specific usual care therapy, 
in terms of medications received or advanced supportive therapies, varied based on the 
individual needs.   
Four of the chosen articles evaluated advance care planning on heart failure (Kernick et 
al., 2018; Nishikawa et al., 2020; Schichtel et al., 2020; Williams et al., 2020). The ACP 
intervention is described as “discussing an individual’s future care plan between the person, their 
family members, surrogate decision-makers, and healthcare providers while considering the 
person’s values, concerns, wishes, life goals, and preferences for future medical care” 
(Nishikawa et al., 2020, p. 6). The goal of ACP then is to ensure the individual receives care with 
respect to these established goals and preferences, with or without the establishment of an 
advance directive (Nishikawa et al., 2020). These ACP interventions were structured to assure 
consistency between participants. The type and methods of ACP varied by study and included 
during specialist palliative care consultation, during outpatient clinic visit, at hospital discharge 
planning, and one video-based training (Nishikawa et al., 2020; Schichtel et al., 2020).  
A total of eight of the selected articles involved palliative care interventions on heart 
failure participants. These palliative care interventions involved palliative care specialists or 
interdisciplinary teams, which may include cardiologists, primary care providers, nurses, and/or 
social workers (Diop et al., 2017; Rogers et al., 2017). The teams assessed and intervened in the 
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various domains of quality of life, including physical, psychosocial, environmental, and spiritual 
(Wong et al., 2016). The setting of the interventions varied and included one with palliative 
telehealth session, three with outpatient clinic interdisciplinary care, one with inpatient palliative 
referral, and two with palliative home visits. The follow-up timelines also varied from 12 to 48 
weeks, with some studies also following the patient until their death. Palliative care protocols 
were established to promote consistency in the delivered interventions, but the interventions 
were also personalized based on each participant’s needs. 
Tools and Instruments 
Instruments used to measure quality of life differed between the studies. These 
instruments included the McGill Quality of Life Questionnaire-Hong Kong version, Kansas City 
Cardiomyopathy Questionnaire, Functional Assessment of Chronic Illness Therapy- Palliative 
14, EuroQol-5D, Chronic Heart Failure Questionnaire, and Minnesota Living with Heart Failure 
Questionnaire. These assessments review participant overall quality of life and symptoms present 
in the physical, social and emotional domains. The comparison between the participant’s 
baseline and follow-up scores is used to determine the impact of the intervention on quality of 
life. In addition, some studies evaluated secondary measures which also impact quality of life, 
including overall symptoms with the Edmonton symptom assessment scale, pain surveys, 
spiritual wellbeing surveys, the hospital anxiety and depression scale, functional assessments, 
satisfaction with care, hospital admission rates, and completion rates of advance directives.   
Research Findings 
The main results of this literature review demonstrated a positive impact of ACP and 
palliative care interventions on health-related quality of life in patients with heart failure when 
implemented along with usual care. Two systematic reviews demonstrate an improvement in 
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quality of life of after ACP intervention; one of which specifically puts emphasis on ACP 
interventions delivered as part of specialist palliative care (Kernick et al., 2018; Nishikawa et al., 
2020). Williams et al. (2020) shows that ACP strengthened the connection between the 
participant’s care preferences and the ultimate delivered care. Since this is the established goal of 
ACP, this finding was particularly significant. However, the large Cochrane systematic review 
and meta-analysis noted an uncertain change to quality of life due to the small number of studies 
and number of participants in each study included in the meta-analysis (Nishikawa et al., 2020). 
This systematic review also cited an overall low to very low quality of available evidence of 
available studies (Nishikawa et al., 2020). 
 The level of evidence provided in the selected articles is mixed. The systematic reviews 
all synthesize data from randomized controlled trials, however, they site an overall low level of 
evidence due to small sample size, high attrition and study design flaws (Nishikawa et al., 2020). 
The largest study included in this review, with 102,746 participants, was of low quality with a 
lack of participant randomization or blinding (Wiskar et al., 2017). The randomized controlled 
trials included were limited in their inability to blind participants to the intervention, as the 
nature of the intervention is a facilitated discussion or consultation with palliative care specialists 
(Nishikawa et al., 2020). Several studies cited high attrition rates, up to 24.4% in one study, due 
to participant withdrawal, unable to reach at follow-up, or died before study completion (Wong 
et al., 2016, p. 1106).   
Seven of the eight articles relating to palliative care interventions reported an 
improvement in quality of life. Two of these randomized control trials also reported the 
improvement as statistically significant findings (Rogers et al., 2017; Wong et al., 2016). The 
only randomized control trial that did not demonstrate an increase in quality of life involved a 
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palliative care telehealth intervention named ENABLE CHF-PC (Bakitas et al., 2020). This 
study also aimed to increase the available palliative care research on racially diverse populations 
(Bakitas et al., 2020). Their sample consisted of 415 participants, with mean age of 63.8, 54.5% 
were African American, 96.9% were NYHA class III, and 91.1% were Protestant (Bakitas et al., 
2020, p. 1206). The study discusses that their results were impacted by the participant’s fairly 
good baseline quality of life scores and high functional status, creating a potential “ceiling 
effect” to the follow-up scores (Bakitas et al., 2020).   
 Selected secondary symptoms related to quality of life were reviewed in the analysis. 
Depression was reviewed in seven of the twelve articles, with six reporting that ACP or palliative 
interventions improved depression (Diop et al., 2017; Kernick et al., 2018; Luo et al., 2016; 
Nishikawa et al., 2020; Rogers et al., 2017; Wong et al., 2016). Anxiety scores were also 
reviewed in four studies, all reporting a reduction in anxiety (Diop et al., 2017; Johnson et al., 
2018; Rogers et al., 2017; Wong et al., 2016). Two studies revealed improved pain scores after a 
palliative care intervention and reported opiates as the most commonly prescribed medication by 
palliative care specialists for those with heart failure (Bakitas et al., 2020; Gandesbery et al., 
2018). Rogers et al. (2017) also determined that palliative care improved spiritual wellbeing in 
heart failure participants. 
 Several articles discussed the intervention’s impact on overall healthcare utilization. The 
rates of repeat hospital admission were significantly lower for both ACP and palliative care 
interventions (Kernick et al., 2018; Wong et al., 2016). Diop et al. (2017) also associated 
palliative care interventions with a statistically significant decrease in emergency department 
visits, length of stay, overall admissions, intensive care unit admissions and urgent care visits (p. 
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89). Reduced utilization of medical services thus decreases cost of care to the individual and 
healthcare system (Diop et al., 2017). 
 The quality of death was reported by the location of death, use of hospice services, and 
survival rates.  Participants receiving palliative care of ACP interventions were more likely to die 
at home rather than the hospital increasing the participant’s preferred place of death (Diop et al., 
2017; Kernick et al., 2018). The rate of hospice care enrollment was also increased in palliative 
care and ACP intervention groups (Diop et al., 2017; Kernick et al., 2018). There are mixed 
results in determining the intervention’s effect on all-cause mortality. Nishikawa et al. (2020) 
reports a higher risk of all-cause mortality after ACP intervention. Then, Diop et al. (2017) notes 
an increased survival rate of 81 days for patients after palliative care interventions.   
Discussion 
 This literature review integrates evidence from the last five years to determine the effect 
of ACP and palliative care interventions on quality of life in individuals with heart failure. Upon 
review of the chosen articles, it was determined that these two interventions could not be 
analyzed separately. Several ACP interventions were applied by palliative care specialists and 
the palliative care interventions often incorporate ACP into their approach. Based on the 
evidence evaluated in this review, though of lower quality, it appears that ACP and palliative 
care interventions improve quality of life in patients with heart failure.   
Through searching the databases, it was clear that the body of knowledge on ACP and 
palliative care in heart failure has grown substantially in the last five years. This is particularly 
notable as previous research in palliative care has been focused primarily on oncology outcomes. 
The level of evidence initially appeared to be high, with the inclusion of five systematic reviews 
synthesizing randomized controlled trial (RCT) data and additional quasi-experimental trials. 
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However, four of these systematic reviews judged the available evidence as low due to small 
sample sizes and study design quality (Kernick et al., 2018; Nishikawa et al., 2020; Schichtel et 
al., 2020; Williams et al., 2020). The studies were limited due to high attrition, control group 
participants receiving palliative interventions during usual care, and inability to blind participants 
(Nishikawa et al., 2020). While blinding participants may not be feasible with these 
interventions, the outcomes may reflect a degree of reporting bias.   
Limitations were also present with the consistency of interventions for each participant. 
Both ACP and palliative care interventions require a patient-centered approach. Several of the 
studies utilized an intervention model or template to promote uniformity between the 
participants. However, each patient has individual palliative care and ACP needs which impacts 
the intervention applied. Some studies argued that this variability between the intervention 
“dose” impacted their results (Bakitas et al., 2020, p. 1207). 
The current ACC/AHA guidelines support ACP and palliative care interventions at all 
stages of heart failure. In the research selected for this review, the participants were primarily in 
NYHA Class III or IV or with previous documented hospitalization for heart failure. This lack of 
inclusion among those with early heart failure, including Class I to II, does impact the 
generalizability of the data. Conversely, heart failure involves an unpredictable and episodic 
disease course, making some participants less willing to engage in these interventions if their 
baseline quality of life is ‘fair’. Bakitas et al. (2020) discussed this possibility as the majority of 
participants were of NYHA class III status. A potential “ceiling effect” in quality of life scores 
was noted as there was little space for improvement from the baseline scores (Bakitas et al., 
2020, 1207). This phenomenon may limit the possible research gains in studies that include 
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participants in Class I and II. A qualitative rather than quantitative study may be more effective 
in explaining the benefit of ACP and palliative care in the early heart failure population.  
While the evidence is low regarding quality of life, the available research does show 
stronger support of symptomatic benefits from the ACP and palliative interventions (Nishikawa 
et al., 2020). Depression, anxiety, pain and spiritual wellbeing all showed improvement after 
interventions. As these symptoms are burdensome, their presence and improvement can also 
affect the participant’s quality of life.   
Healthcare resource utilization is presented as the rate of rehospitalization and cost of 
care. While the healthcare system values a lower heart failure readmissions rate due to greater 
financial reimbursements, the patient also benefits with lower healthcare costs and less time in 
the hospital. Research demonstrating a reduction in cost after ACP and palliative care may 
provide further incentive to implement these interventions in practice.   
The quality of death was frequently analyzed as an outcome of ACP and used to 
determine if the participant’s established wishes are upheld. Neither of these interventions intend 
to precipitate death, rather to alleviate burdensome symptoms for these patients and optimize the 
patient’s goals of care. The available data on all-cause mortality following ACP and palliative 
care is uncertain, with some studies reporting an increase and others with life prolonging 
evidence. However, this data can be misleading, as it does not reflect the patient or caregiver 
satisfaction with end-of-life care or the use of life-sustaining treatments (Nikshikawa et al, 
2020).   
Gaps in Literature 
 A number of personal, social, and environmental factors can influence the outcomes of 
palliative care and ACP. Overall, there is a great need for further research on these subjects in 
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order to assist their integration into usual care for individuals with heart failure. This literature 
review exposed the lack of evidence regarding these interventions being applied in early heart 
failure, including Class I and II. Although heart failure in early stages can be stable with minimal 
symptoms, the disease is subjected to sudden changes and exacerbations. While ACP discussion 
often take place during these exacerbations, it is also important to discuss ACP early in the 
disease process. The possibility of a sudden fatal arrhythmia further depicts the disease’s 
unpredictability and need for early intervention (Luo et al., 2016). The clinician can regularly 
review advance care plans, as the patient’s values and wishes may change over time (Nishikawa 
et al., 2020). While the ACC/AHA 2013 heart failure guidelines support the early 
implementation of ACP and palliative care, these interventions are often not applied until later 
stages. The lack of research on this population of early heart failure may influence current 
practices. Further research on barriers to application should also be explored.   
 One challenge of this review was to compare the studies in which the interventions 
greatly differed in framework. Even the ACP studies involved delivering the intervention at a 
palliative care consultation, with hospital discharge planning, and with a video-based training. 
Further research is needed to compare these interventions, determine the most effective form, 
and analyze cost of delivery. Several studies highlight the need for an interdisciplinary approach 
to both ACP and palliative care. Shared decision-making among the patient, family members, 
palliative care specialist, primary care provider, and the cardiology team may bring about 
varying viewpoints that can support the patient’s overall quality of life. Future studies evaluating 
palliative care provided by an interdisciplinary team versus palliative care specialists alone will 
be beneficial. Similarly, comparing the ACP intervention applied in a primary care or cardiology 
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visit as opposed to a component of specialist palliative care may help to determine the most cost-
effective approach for these patients. 
There is a need for more research on cultural and racial values and their impact on ACP 
and perceptions of palliative care. Discussions regarding death are not acceptable in some 
cultures, and interventions may be inappropriate to generalize to other cultures. Bakitas et al. 
(2020) evaluated a “culturally based, palliative care intervention” with 54.4% of participants 
identified as African American (p. 1203). However, their results demonstrated no significant 
change in quality of life or mood at the 16-week follow-up (Bakitas et al., 2020). These results 
may demonstrate a conflict in cultural values and the intervention provided. Previous research 
has shown African Americans have unique barriers to palliative medicine, including lack of 
knowledge about prognosis, a desire for aggressive treatment, medical mistrust, family member 
resistance, and lack of insurance (Rhodes et al., 2015). Cultural sensitivity is necessary to 
examine when evaluating these interventions, the instruments used during research, and in 
applying ACP or palliative care into practice. Future research is needed to analyze the use of the 
ACP and palliative care interventions onto participants in different sociocultural and spiritual 
backgrounds.  
Implications for Research 
 In addition to addressing the identified gaps in the literature, there is a need to gather high 
quality evidence on this topic through large scale RCTs. Current research also is limited by the 
heterogeneity of study methods, populations, interventions, measuring instruments, and 
outcomes evaluated (Diop et al., 2017). In order to conduct a future high-quality meta-analysis, 
data from RCTs must be more homogenous. Future studies should further explore the effects of 
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ACP and palliative care interventions on quality of life and whether the end-of-life care received 
upholds to their preferences established by ACP.  
The barriers to ACP and palliative care application should also be explored, including the 
perceived distress to the patient or family in discussing future goals of care and end-of-life 
preferences. There is also a need to expand palliative care services to the rural and underserved 
communities. Future research evaluating the effect of telehealth palliative services for these 
communities which lack an in-person option. To support the expansion of palliative care services 
in the country, the overall cost-benefit analysis of services provided verses those saved through 
lower healthcare resource utilization should be analyzed.  
Implications for Practice 
This literature review highlighted the growing body of research available on ACP and 
palliative care in the heart failure population. This research provides an evidence basis for these 
interventions to be applied into practice. The Centers for Medicare and Medicaid Services 
approved reimbursement for advance care planning and palliative care services (Williams et al., 
2020). Though funding may be present and support from current research and heart failure 
guidelines may be present, the application of ACP and palliative care in practice remains low.   
Possible barriers to application in practice include the unpredictable disease trajectory, 
difficulty for providers to determine appropriate timing, the patient’s poor understanding of 
disease progression, and patient or provider displeasure in discussing end of life planning 
(Nishikawa et al., 2020; Luo et al., 2016). The recommended timing of these interventions is also 
inconsistent. Schichtel et al. (2020) suggests ACP be implemented at significant milestones to 
promote better patient engagement, such as “after an unscheduled hospital admission, before 
hospital discharge or after a deterioration in the patient’s health status” (p. 882). It is uncertain if 
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the timing of the intervention impacts its success. If patients are not engaged in the discussion, 
the intervention may be explained but be poorly understood.  
 Of the ACP and palliative care interventions, it appears most effective if implemented by 
palliative care specialists in collaboration with an interdisciplinary team. However, the 
practicality of this approach may be poor given the deficit of palliative care specialists and large 
portion of heart failure patients. The ideal action, given current resources, is to incorporate ACP 
and palliative care interventions into the usual heart failure care in primary care and cardiology 
outpatient visits. Then a referral to palliative care specialists would occur for complex cases or 
difficult to control symptoms.   
Implications for Policy 
 Current public and private medical insurance agencies offer reimbursement for ACP and 
palliative care referrals. However, there continues to be low application of these interventions 
into practice. Future policy changes can assist in overcoming practice barriers. Policies promoted 
to offer financial incentives for ACP and palliative care interventions. Current policies should be 
evaluated for possible hinderances to practice. The buy-in of key policy stakeholders is important 
for these changes to be successful; these individuals should receive education on the benefits of 
ACP and palliative care to reduce healthcare resource utilization and spending. Hospitals are 
currently penalized for heart failure readmissions, and palliative care can be promoted to prevent 
these readmissions. Policy may also inform the public about ACP and palliative care including 
the benefit to chronic disease symptoms, healthcare utilization, and when to request these 
services.  
Implications for Education 
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 The acceptance of ACP and palliative care by clinicians proves to be a barrier to 
application. There continues to be a misconception that palliative care equates to hospice care, 
which prevents some clinicians from offering palliative care referrals. Additional training is 
needed for both primary care providers and cardiology specialists regarding the benefits of ACP 
and palliative care for heart failure patients. Clinicians should be educated on these interventions 
as a way to improve provider-patient communication, patient satisfaction of care and quality of 
life. For heart failure patients, some clinicians may feel uncomfortable with introducing 
palliative care and ACP due to the uncertain disease trajectory and a perceived patient aversion 
in end-of-life discussions (Luo et al., 2016). To overcome these barriers, methods of 
incorporating ACP and palliative interventions into usual care should be incorporated into 
medical and nursing curriculum. Continuing education classes also provide an opportunity to 
explore these interventions and overcome barriers to application. 
Conclusion 
 Heart failure is a progressive disease with a significant level of symptom burden, 
decrease in functional status, and psychologic distress. Those who suffer from heart failure can 
experience a reduction in quality of life and greater need for palliative care and ACP. Compared 
to oncology patients, those with heart failure have considerably less utilization of these services. 
This literature review revealed a growing amount of available heart failure specific research 
evaluating ACP and palliative care interventions. A total of twelve articles were chosen for 
analysis to determine the interventions impact on quality of life.   
  The evidence analyzed in this review do support that ACP and palliative care increase 
the quality of life in heart failure. Review of secondary symptomatic outcomes also demonstrate 
benefit to depression, anxiety, pain, and spiritual wellbeing. Data reveal a decrease in 
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readmission rates and increase in quality of death. The interventions’ impact on all-cause 
mortality is uncertain and ultimately does not reflect the patient’s satisfaction with care or use of 
life-sustaining treatments.   
The overall quality of this evidence is low due to inability to blind participants, small 
sample sizes, high attrition rates, and inconsistent control of variables. Future research is needed 
to evaluate the impact of ACP and palliative care on early heart failure and among those with 
different cultural backgrounds. A comparison between interventions is also needed to optimize 
the delivery in practice. Application of these interventions in practice is supported by Medicare 
and Medicaid reimbursement and the current heart failure guidelines. Practice change must 
overcome barriers including a deficiency of palliative specialists, provider uncertainty in 
delivering the interventions, and misperceptions or lack of engagement from the patient. Adding 
these interventions into the usual care for heart failure is a more realistic approach and allows all 
patients access to services. 
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Appendix 
Table 1 
Database Search Description 
Database (or Search Engine) 
 
Restrictions Added to Search 
 
Dates Included in Database General Subjects Covered by 
Database 
1. Academic Search Premier (ASP) Full text; English Language; Scholarly 
Journals (Peer Reviewed) 
2015 through 2020 Provides citations and abstracts to 
articles, as well as full text of articles 
from over 4,600 publications, covering 
almost every academic subject. 
2. CINAHL Plus with Full Text (CINAHL) Full Text; English Language; Peer 
Reviewed 
2015 through 2020 Provides full text access to e-books 
about nursing and 29 core nursing 
journals. Also provides citations and 
abstracts to articles, books, dissertations, 
proceedings, and other materials about 
all aspects of nursing and allied health, 
including cardiopulmonary technology, 
emergency service, health education, 
medical/laboratory, medical assistant, 
medical records, occupational therapy, 
physical therapy, physician assistant, 
radiologic technology, social 
service/health care, and more. 
3. Cochrane Database of Systematic Reviews 
(Cochrane) 
Full Text 2015 through 2020 Cochrane Database of Systematic 
Reviews contains full text articles, as 
well as protocols focusing on the effects 
of healthcare. Data is evidence-based 
medicine and is often combined 
statistically (with meta-analysis) to 
increase the power of the findings of 
numerous studies, each too small to 
produce reliable results individually. 
4. PubMed Full Text; English Language; Human 
species 
2015 through 2020 Provides citations, abstracts, and 
selected full text to articles about 
"medicine, nursing, dentistry, veterinary 
medicine, the health care system, and the 
preclinical sciences." 
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Database (or Search Engine) 
 
Restrictions Added to Search 
 
Dates Included in Database General Subjects Covered by 
Database 
5. SAGE Journals (SAGE) Full Text 2015 through 2020 This database includes all of the 
databases that we formerly had under the 
“Sage Full-Text” moniker. It includes: 
Communication Studies, Criminology, 
Education, Health Sciences & Nursing, 
Management & Organization Studies, 
Materials Science, Non-Profit 
Leadership, Political Science, 
Psychology, Sociology, and Urban 





Data Abstraction Process 
Date of 
Search 








10.20.20 “Advance care planning” AND “Heart failure” 114 24 2 251 2392 
 “Advance care planning” AND “Heart failure” (subject 
search) 
22 49 0 x x 
 “Advance care planning” AND “Cardiac failure” 74 49 (2) 0 264 99 
 “Advance care planning” AND “Heart failure” AND 
“Quality of life” 
19 (2) 23 (1) 2 (1) 91 1781 
10.21.20 “Advance care planning” AND “Heart failure” AND 
“Wellbeing” 
3 1 0 7 (3) 219 
10.24.20 “Advance care planning” AND “Heart failure” AND 
“Primary care” 
5 3 0 6 39 (3) 
11.13.20 “Advance care planning” AND “Heart failure” (title search) 3 (1) 3 (2) 1 (1) 4 (0) 4 (3) 
11.13.20 “Palliative care” AND “heart failure” X 0 X 292 846 
11.13.20 “Palliative care” AND “heart failure” (title search) X X X  22 
11.13.20 Review of references 3     
*BOLD = articles reviewed for match with systematic review inclusion criteria (parentheses indicate those articles meeting inclusion criteria) 
 
Table 3 
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Akyar, I., Dionne-Odom, J. N., & Bakitas, M. A. (2019). Using patients and 
their caregivers feedback to develop ENABLE CHF-PC: An early palliative 
care intervention for advanced heart failure. Journal of palliative care, 34(2), 
103–110. https://doi-org.ezproxy.mnsu.edu/10.1177/0825859718785231 
Excluded This study is intended to develop and evaluate the palliative care 
intervention, ENABLE CHF-PC. Research pertains to the tool itself 
rather than patient outcomes. 
Bakitas, M. A., Dionne-Odom, J. N., Ejem, D. B., Wells, R., Azuero, A., 
Stockdill, M. L., Keebler, K., Sockwell, E., Tims, S., Engler, S., Steinhauser, 
K., Kvale, E., Durant, R. W., Tucker, R. O., Burgio, K. L., Tallaj, J., Swetz, K. 
M., & Pamboukian, S. V. (2020). Effect of an early palliative care telehealth 
intervention vs usual care on patients with heart failure: The ENABLE CHF-
PC randomized clinical trial. JAMA internal medicine, 180(9), 1203–1213. 
https://doi-org.ezproxy.mnsu.edu/10.1001/jamainternmed.2020.2861 
Included Determines the effect of palliative care telehealth intervention on 
quality of life, mood, global health, pain, and resource use in patients 
with HF. 
Brännström, M., & Jaarsma, T. (2015). Struggling with issues about 
cardiopulmonary resuscitation (CPR) for end-stage heart failure 
patients. Scandinavian Journal of Caring Sciences, 29(2), 379–385. 
https://doi-org.ezproxy.mnsu.edu/10.1111/scs.12174 
Excluded The study evaluates barriers of healthcare provider to implement 
palliative care discussions but not review the impact palliative care 
has on the patient. 
Chandar, M., Brockstein, B., Zunamon, A., Silverman, I., Dlouhy, S., 
Ashlevitz, K., Tabachow, C., Lapin, B., Ewigman, B., Mazzone, T., & Obel, J. 
(2017). Perspectives of health-care providers toward advance care planning in 
patients with advanced cancer and congestive heart failure. The American 
journal of hospice & palliative care, 34(5), 423–429. https://doi-
org.ezproxy.mnsu.edu/10.1177/1049909116636614 
Excluded This study evaluates the attitudes of cardiologists towards ACP. 
Barriers to implementing ACP were addressed, but not how these 
discussions benefit the patient.  
Diop, M. S., Rudolph, J. L., Zimmerman, K. M., Richter, M. A., & Skarf, L. 
M. (2017). Palliative care interventions for patients with heart failure: A 
systematic review and meta-analysis. Journal of palliative medicine, 20(1), 
84–92. https://doi-org.ezproxy.mnsu.edu/10.1089/jpm.2016.0330 
Included This is a systematic review and meta-analysis on the impact of 
palliative intervention for patients with heart failure. Outcomes 
include quality of life, satisfaction, clarification of care preferences, 
and risk of rehospitalization. 
El-Jawahri, A., Paasche-Orlow, M. K., Matlock, D., Stevenson, L. W., Lewis, 
E. F., Stewart, G., Semigran, M., Chang, Y., Parks, K., Walker-Corkery, E. S., 
Temel, J. S., Bohossian, H., Ooi, H., Mann, E., & Volandes, A. E. (2016). 
Randomized, controlled trial of an advance care planning video decision 






A randomized control study on the use of a video decision support 
tool for those with heart failure. Outcomes involve patient’s desire for 
CPR/intubation rather than quality of life. 
Gandesbery, B., Dobbie, K., & Gorodeski, E. Z. (2018). Outpatient palliative 
cardiology service embedded within a heart failure clinic: Experiences with an 
emerging model of care. The American journal of hospice & palliative 
Included The study characterized patients in an outpatient palliative cardiology 
service on their most common complaints, advance directive status, 
medications used, and mortality. These distressing symptoms 
encountered heavily impact the patient’s quality of life. 







care, 35(4), 635–639. https://doi-
org.ezproxy.mnsu.edu/10.1177/1049909117729478 
Johnson, M. J., McSkimming, P., McConnachie, A., Geue, C., Millerick, Y., 
Briggs, A., & Hogg, K. (2018). The feasibility of a randomized controlled trial 
to compare the cost-effectiveness of palliative cardiology or usual care in 
people with advanced heart failure: Two exploratory prospective 
cohorts. Palliative medicine, 32(6), 1133–1141. https://doi-
org.ezproxy.mnsu.edu/10.1177/0269216318763225 
Excluded This is a feasibility study reviewing variables and population data 
prior to RCT, no data regarding the palliative care intervention is 
evaluated. 
Kernick, L. A., Hogg, K. J., Millerick, Y., Murtagh, F., Djahit, A., & Johnson, 
M. (2018). Does advance care planning in addition to usual care reduce 
hospitalisation for patients with advanced heart failure: A systematic review 
and narrative synthesis. Palliative medicine, 32(10), 1539–1551. https://doi-
org.ezproxy.mnsu.edu/10.1177/0269216318801162 
Included A systematic review evaluating the addition of ACP to usual care at 
reducing hospitalization in adults with heart failure. Outcomes also 
evaluate impact on quality of life, symptoms, use of specialist 
palliative care, and end-of-life preferences. 
Luo, N., Rogers, J. G., Dodson, G. C., Patel, C. B., Galanos, A. N., Milano, C. 
A., O'Connor, C. M., & Mentz, R. J. (2016). Usefulness of palliative care to 
complement the management of patients on left ventricular assist devices. The 
American journal of cardiology, 118(5), 733–738. https://doi-
org.ezproxy.mnsu.edu/10.1016/j.amjcard.2016.06.010 
Included This article describes the role and barriers of implementing palliative 
interventions for adults with heart failure on mechanical circulatory 
support. The patient’s benefit to palliative care include improvement 
of symptoms and increase in quality of life.  
Malhotra, C., Sim, D. K., Jaufeerally, F., Vikas, N. N., Sim, G. W., Tan, B. C., 
Ng, C. S., Tho, P. L., Lim, J., Chuang, C. Y., Fong, F. H., Liu, J., & 
Finkelstein, E. A. (2016). Impact of advance care planning on the care of 
patients with heart failure: Study protocol for a randomized controlled 
trial. Trials, 17(1), 285. https://doi-org.ezproxy.mnsu.edu/10.1186/s13063-
016-1414-1 
Excluded This article is the study protocol which was evaluated prior to 
conducting a randomized control trial.  
Metzger, M., Song, M. K., Ward, S., Chang, P. P., Hanson, L. C., & Lin, F. C. 
(2016). A randomized controlled pilot trial to improve advance care planning 
for LVAD patients and their surrogates. Heart & Lung:The Journal of Critical 
Care, 45(3), 186–192. https://doi-
org.ezproxy.mnsu.edu/10.1016/j.hrtlng.2016.01.005 
Excluded Studies an educational intervention on patient-surrogate congruence 
in goals of care, patient’s decisional conflict and surrogates decision-
making confidence. Does include ACP, but does not analyze its 
impact on the patient’s quality of life post-intervention. 
Nishikawa, Y., Hiroyama, N., Fukahori, H., Ota, E., Mizuno, A., Miyashita, 
M., Yoneoka, D., Kwong, J. S., & Kwong, J. S. (2020). Advance care planning 
for adults with heart failure. Cochrane Database of Systematic Reviews, 2. 
Included Systematic review of 9 studies showing the effects of ACP compared 
to usual care for heart failure patients. Includes review of the 
intervention impact quality of life. 
Rogers, J. G., Patel, C. B., Mentz, R. J., Granger, B. B., Steinhauser, K. E., 
Fiuzat, M., Adams, P. A., Speck, A., Johnson, K. S., Krishnamoorthy, A., 
Yang, H., Anstrom, K. J., Dodson, G. C., Taylor, D. H., Jr, Kirchner, J. L., 
Mark, D. B., O'Connor, C. M., & Tulsky, J. A. (2017). Palliative care in heart 
failure: The PAL-HF randomized, controlled clinical trial. Journal of the 
Included A randomized control trial evaluating a palliative care intervention in 
advanced heart failure patients on quality of life, anxiety, depression, 
and spiritual well-being compared to usual care. 







American College of Cardiology, 70(3), 331–341. https://doi-
org.ezproxy.mnsu.edu/10.1016/j.jacc.2017.05.030 
Sadeghi, B., Walling, A. M., Romano, P. S., Ahluwalia, S. C., & Ong, M. K. 
(2016). A hospital-based advance care planning intervention for patients with 
heart failure: A feasibility study. Journal of palliative medicine, 19(4), 451–
455. https://doi-org.ezproxy.mnsu.edu/10.1089/jpm.2015.0269 
Excluded Reviews ACP impact on completion rates of POLST forms or 
advanced directives. Does not evaluate intervention impact on quality 
of life for patients. 
Sahlen, K. G., Boman, K., & Brännström, M. (2016). A cost-effectiveness 
study of person-centered integrated heart failure and palliative home care: 
Based on a randomized controlled trial. Palliative medicine, 30(3), 296–302. 
https://doi-org.ezproxy.mnsu.edu/10.1177/0269216315618544 
Included A randomized controlled trial studying a palliative home care 
intervention on healthcare costs and quality of life for patient in 
severe and chronic heart failure. 
Schichtel, M., Wee, B., Perera, R., & Onakpoya, I. (2020). The effect of 
advance care planning on heart failure: A systematic review and meta-
analysis. JGIM: Journal of General Internal Medicine, 35(3), 874–884. 
https://doi.org/10.1007/s11606-019-05482-w 
Included A systematic review of 14 RCT’s analyzing the impact of advance 
care planning on quality of life and patient satisfaction with end-of-
life care, and the quality of end-of-life communication. High level of 
evidence. 
Thoonsen, B., Vissers, K., Verhagen, S., Prins, J., Bor, H., van Weel, C., 
Groot, M., & Engels, Y. (2015). Training general practitioners in early 
identification and anticipatory palliative care planning: A randomized 
controlled trial. BMC Family Practice, 16(1), 1–12. https://doi-
org.ezproxy.mnsu.edu/10.1186/s12875-015-0342-6 
Excluded Reviews general practitioners’ ability to identify patients in need of 
palliative care and implement palliative interventions. Does not 
review the quality of life from these palliative interventions.  
Van Scoy, L. J., Green, M. J., Dimmock, A. E., Bascom, R., Boehmer, J. P., 
Hensel, J. K., Hozella, J. B., Lehman, E. B., Schubart, J. R., Farace, E., 
Stewart, R. R., & Levi, B. H. (2016). High satisfaction and low decisional 
conflict with advance care planning among chronically ill patients with 
advanced chronic obstructive pulmonary disease or heart failure using an 
online decision aid: A pilot study. Chronic illness, 12(3), 227–235. https://doi-
org.ezproxy.mnsu.edu/10.1177/1742395316633511 
Excluded The study evaluates individuals of different chronic disease states and 
primary outcome is the patients’ satisfaction of using an ACP tool. 
Wells, R., Stockdill, M. L., Dionne-Odom, J. N., Ejem, D., Burgio, K. L., 
Durant, R. W., Engler, S., Azuero, A., Pamboukian, S. V., Tallaj, J., Swetz, K. 
M., Kvale, E., Tucker, R. O., & Bakitas, M. (2018). Educate, nurture, advise, 
before life ends comprehensive heartcare for patients and caregivers 
(ENABLE CHF-PC): Study protocol for a randomized controlled 
trial. Trials, 19(1), 422. https://doi-org.ezproxy.mnsu.edu/10.1186/s13063-
018-2770-9 
Excluded This analyzes the study protocol rather than results of the palliative 
care intervention.  
Williams, M. T., Kozachik, S. L., Karlekar, M., & Wright, R. (2020). Advance 
care planning in chronically ill persons diagnosed with heart failure or chronic 
obstructive pulmonary disease: An integrative review. The American journal 
Included An integrative review analyzing advance care planning discussions in 
the acute care setting for patients with heart failure and COPD. Study 
outcomes evaluated the benefit of ACP improving communication 







of hospice & palliative care, 37(11), 950–956. https://doi-
org.ezproxy.mnsu.edu/10.1177/1049909120909518 
surrounding care preferences, strengthened connection between 
preferred and delivered care, and increased patient involvement.  
Wiskar, K., Celi, L. A., Walley, K. R., Fruhstorfer, C., & Rush, B. (2017). 
Inpatient palliative care referral and 9-month hospital readmission in patients 
with congestive heart failure: A linked nationwide analysis. Journal of Internal 
Medicine, 282(5), 445–451. https://doi-
org.ezproxy.mnsu.edu/10.1111/joim.12657 
Included A retrospective linked analysis of hospital readmissions for heart 
failure exacerbations. Primary outcome is readmission rate of end-
stage heart failure after palliative care consult. Reviews how the 
reduction of hospitalizations increase patient quality of life. 
Wong, F. K., Ng, A. Y., Lee, P. H., Lam, P. T., Ng, J. S., Ng, N. H., & Sham, 
M. M. (2016). Effects of a transitional palliative care model on patients with 
end-stage heart failure: A randomised controlled trial. Heart (British Cardiac 
Society), 102(14), 1100–1108. https://doi-
org.ezproxy.mnsu.edu/10.1136/heartjnl-2015-308638 
Included A randomized control trial examining the effects of home-based 
palliative care for patients with heart failure. Outcomes include 
readmission rates, symptom control, and quality of life. 
Note. ACP = Advance care planning; POLST = physician orders for life-sustaining treatment; CPR = Cardiopulmonary resuscitation; 
COPD = Chronic obstructive pulmonary disease 
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intervention vs usual care on 
patients with heart failure: The 
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clinical trial. JAMA internal 
medicine, 180(9), 1203–1213. 
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Mood: Hospital Anxiety 
and Depression Scale 
[HADS] 
 



























-No significant differences were 
noted for QOL or mood scores 
between the intervention and 
control groups 
-Secondary outcomes of pain 
intensity and pain interference 
with daily life were better in the 
intervention group. 
-Early palliative care intervention 
improved pain intensity and 
interference with daily life. 
-The lack of significant differences in 
QOL scores may be related to the high 
proportion of patients with NYHA 
class III status with fairly good 
baseline QOL and functional status. 
-Nearly half of the intervention group 
were unable to attend the in-person 
palliative consultation and 39% did 
not receive the full telephone coaching 
sessions, which presents a study 
limitation. 
-Future research is needed to evaluate 
the interventions impact on patients 
with higher baseline symptom burden 
and poorer QOL. 
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Palliative care interventions for 
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-Improvement of patient QOL in 
83% of studies 
-Improvement of patient 
satisfaction of care in 67% of 
symptoms 
-Improvement of patient 
symptoms most frequently seen 
with dyspnea, sleep quality, 
depression and anxiety 
-Increase in advance directive 
completion in 71% of studies 
-Decrease in emergency 
department visits, length of stay, 
overall admissions, intensive care 
unit admissions, urgent care, and 
primary care visits 
-Current evidence suggests that home 
and team-based palliative 
interventions for HF patients improve 
patient-centered outcomes, 
documentation of patient preferences, 
and reduce utilization of medical 
services. 
-Research encourages early palliative 
care interventions for HF patients. 
-Further research is needed to address 
the impact of social determinants of 
health and family involvement on 
patient-centered outcomes when 
palliative care is applied to the HF 
population. 
Gandesbery, B., Dobbie, K., & 
Gorodeski, E. Z. (2018). 
Outpatient palliative cardiology 
service embedded within a heart 
failure clinic: Experiences with an 
emerging model of care. The 
American journal of hospice & 



















































-The most frequently addressed 
issues were pain management 
(55%) and advanced care 
planning (54%) 
-The most common palliative 
medications prescribed were 
opiates (48%), laxatives (22%), 
anti-neuropathies (22%), and 
antidepressants (16%). 
-Embedding palliative medicine 
services in a HF outpatient clinic is 
feasible. 
-Patients seen had a variety of QOL 
limiting symptoms and were 
medically managed by palliative care 
interventions. 
-Evidence favors the formation of 
dedicated HF palliative care clinics. 
Kernick, L. A., Hogg, K. J., 
Millerick, Y., Murtagh, F., Djahit, 
A., & Johnson, M. (2018). Does 
advance care planning in addition 
The assess 
whether ACP, 



















-increased referral and use of 
palliative services 
-Trials of ACP by specialist palliative 
care intervention show benefit to 
patient-referred place of care and 
death and reduced hospital 
admission/time in hospital 
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to usual care reduce 
hospitalisation for patients with 
advanced heart failure: A 
systematic review and narrative 
synthesis. Palliative 







quality of death 
in adults with 
HF. 
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-supported deaths in the patient-
preferred place 
 
-ACP improved QOL and 
burdensome symptoms, though 
measurement instruments varied 
across studies 
-Specialty palliative care is a scarce 
resource. It is feasible for ACP to be 
implemented into core cardiology 
care, with access to palliative 
specialist as needed  
-Future research should evaluate 
possible harms of ACP. 
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Usefulness of palliative care to 
complement the management of 
patients on left ventricular assist 
devices. The American journal of 







barriers to use 













N/A N/A Barriers include:  
-an uncertainty of disease 
progression, unlike other chronic 
diseases 
-real or perceived patient aversion 
to end-of-life planning 
 
The role of proactive palliative 
care consultation prior to MCS 
therapy can assist patients and 
families understand options, 
define values for QOL, clarify 
goals of LVAD therapy, and 
document end-of-life preferences. 
 
As technology evolves, the use of 
MCS will evolve and may be utilized 
in earlier stages of HF. In this 
scenario, the role of palliative care 
will also need to evolve and be 
implemented earlier. 
Nishikawa, Y., Hiroyama, N., 
Fukahori, H., Ota, E., Mizuno, A., 
Miyashita, M., Yoneoka, D., 
Kwong, J. S., & Kwong, J. S. 
(n.d.). Advance care planning for 
adults with heart 
failure. Cochrane Database of 
Systematic Reviews, 2. 
To assess the 
effects of ACP 
in adults with 
HF compared to 
usual care 
strategies that 















Variable across studies 
evaluated 
ACP ACP effects: 
-increases completion of 
documentation by medical staff 
regarding discussions with 
participants about ACP processes 
-may increase all-cause mortality 
-may improve depression scores 
-uncertain impact on QOL or 
quality of communication with 
providers 
ACP may help promote 
documentation by healthcare 
providers about ACP process and lead 
to improve in participant depression. 
However, the quality of evidence was 
low. 
Rogers, J. G., Patel, C. B., Mentz, 
R. J., Granger, B. B., Steinhauser, 
K. E., Fiuzat, M., Adams, P. A., 
Speck, A., Johnson, K. S., 
Krishnamoorthy, A., Yang, H., 
Anstrom, K. J., Dodson, G. C., 
Taylor, D. H., Jr, Kirchner, J. L., 
Mark, D. B., O'Connor, C. M., & 
To assess the 
impact of an 
interdisciplinar




















of Chronic Therapy- 
Palliative Care scale, 












-Palliative care had significant 
improvement in QOL scores at 6 
months 
-Depression, anxiety, and spiritual 
well-being improved in the 
intervention group 
-The intervention had no impact 
on rate of rehospitalization or 
mortality 
PAL-HF increases evidence to support 
the use of palliative care interventions 
to improve health-related quality of 
life in end-stage HF patients.   















Intervention Findings Implications 
 
Tulsky, J. A. (2017). Palliative 
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effectiveness study of person-
centered integrated heart failure 
and palliative home care: Based 
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-The intervention group had a 
gain of 0.25 quality-adjusted life 
years 
-Significant cost reduction with 
the intervention group, related to a 
reduction in hospital care and 
emergency services 
The PREFER intervention saves 
financial resources while improving 
quality of life for patient in HF. 
 
Schichtel, M., Wee, B., Perera, 
R., & Onakpoya, I. (2020). The 
effect of advance care planning 
on heart failure: A systematic 
review and meta-analysis. JGIM: 
Journal of General Internal 




the effect of 











-had a moderate improvement of 
QOL, patient satisfaction with 
end-of-life care, and the quality of 
end-of-life communication for 
patients suffering from HF 
-Is most effective when 
introduced at significant disease 
milestones 
To facilitate better engagement with 
ACP: 
-introduce ACP at a significant 
milestone in the disease trajectory 
-offer follow-up appointments to 
clarify and adjust care choices 
-offer involvement of family members 
or health care proxy 
-work in a multidisciplinary team and 
not in isolation within a single 
medical specialty. 
Williams, M. T., Kozachik, S. L., 
Karlekar, M., & Wright, R. 
(2020). Advance care planning in 
chronically ill persons diagnosed 
with heart failure or chronic 
obstructive pulmonary disease: 
An integrative review. The 
American journal of hospice & 

















Variable across studies 
evaluated  
ACP -Improved patient attitudes 
toward ACP 
-Effective communication 
surrounding care preferences  
-Strengthened connection between 
preferred and delivered care 
-Increased patient involvement in 
ACP 
Chronic diseases, including HF, have 
a high symptom burden punctuated by 
exacerbations, making it difficult 
identify the most beneficial time for 
ACP discussions. Future research is 
needed to evaluate the optimal 
timeline of ACP interventions in this 
population. 
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(2017). Inpatient palliative care 
referral and 9-month hospital 
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Age, gender, insurance 
coverage, discharge 
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hospitalization, DNR 
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-Only 2.2% of patients admitted 
with HF had a palliative care visit 
as inpatients 
-Patients who had received a 
palliative care visit were less 
likely to be readmitted for HF or 
for any cause during the 9-month 
follow-up period 
-The average hospital cost during 
the follow-up period for the non-
palliative care group were 
$77,643 per patient, compared to 
the $23,200 per patient who had 
received palliative care 
consultation 
Inpatient palliative care visits 
significantly lowered rates of all-cause 
and HF-specific readmission in the 
subsequent 9 months and lowering 
healthcare costs. However, the study 
is limited in its ability to capture costs 
of home care, skilled nursing 
facilities, and hospice care that may be 
increased after palliative care 
consultation. 
Wong, F. K., Ng, A. Y., Lee, P. 
H., Lam, P. T., Ng, J. S., Ng, N. 
H., & Sham, M. M. (2016). 
Effects of a transitional palliative 
care model on patients with end-
stage heart failure: A randomised 
controlled trial. Heart (British 






















-Count of readmissions 
within 4 and 12 weeks 










ne calls by a 
nurse case 
manager in 




-The intervention group had a 
significantly lower readmission 
rate than control at 12 weeks 
-There was no difference in 
readmission rates between groups 
at 4 weeks 
-The intervention group 
experienced significantly higher 
clinical improvement of 
depression, dyspnea, and total 
ESAS score 
-There was a significant 
improvement to QOL in the 
control group 
-This study provides evidence of the 
effectiveness of post-discharge 
palliative care program in reducing 
readmissions and improving symptom 
control among patients with HF 
-Organizational support with referral 
guidelines between medical and 
palliative care physicians may 
promote further utilization of this 
intervention 
Note. RCT = Randomized controlled trial; HF = Heart failure; ACP = Advance care planning; QOL = Quality of life 
 
